In the latest trading session, 3,436,722 Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares changed hands as the company’s beta touched 0.67. With the company’s most recent per
In recent trading session, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) saw 3,306,849 shares changing hands at last check today with its beta currently measuring 0.64. Company’s recent
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has a beta value of 0.64 and has seen 3,813,207 shares traded in the recent trading session. The company, currently valued
During the last session, Inovio Pharmaceuticals, Inc. (NASDAQ:INO)’s traded shares were 6,460,787, with the beta value of the company hitting 0.76. At the end of
In today’s recent session, 9,796,882 shares of the Inovio Pharmaceuticals, Inc.(NASDAQ:INO) have been traded, and its beta is 0.76. Most recently the company’s share price
Inovio Pharmaceuticals, Inc. (NASDAQ:INO)’s traded shares stood at 2,852,448 during the latest session, with the company’s beta value hitting 0.75. At the last check today,
In the latest trading session, 3,150,579 Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares changed hands as the company’s beta touched 0.75. With the company’s most recent per
In recent trading session, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) saw 60,467,271 shares changing hands at last check today with its beta currently measuring 0.76. Company’s recent
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has a beta value of 0.76 and has seen 4,792,992 shares traded in the recent trading session. The company, currently valued
During the recent session, Inovio Pharmaceuticals, Inc. (NASDAQ:INO)’s traded shares were 3,680,224, with the beta value of the company hitting 0.76. At the last check,